To access this element change to forms mode OFF
Grant Award View - GA203580
Development of a defective interfering RNA based antiviral approach to...
GA ID:
GA203580
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
1-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$815,218.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Development of a defective interfering RNA based antiviral approach to treat infections by SARS-CoV-2 and emerging variants
Purpose:
Specific therapy for severe disease caused by SARS-CoV-2 is limited. The ability of viruses to become resistant to a therapy may be obstacle for antiviral development. This project develops a unique platform, using virus-specific antiviral RNA, as a unique and possibly “antiviral-resistance†proof approach that could be deployed as a therapeutic for COVID-19 and also help to solve the challenge of viral pandemics from known and unknown viruses, especially other human pathogenic coronaviruses.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011398
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Council of the Queensland Institute of Medical Research
Recipient ABN:
31 411 813 344
Grant Recipient Location
Suburb:
Herston
Town/City:
Herston
Postcode:
4006
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, QLD
Postcode:
Multiple
Country:
AUSTRALIA